{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T04:30:39Z","timestamp":1743568239425,"version":"3.32.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T00:00:00Z","timestamp":1722643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"DOI":"10.1007\/s00384-024-04696-7","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T04:01:50Z","timestamp":1722657710000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predictive value of flexible proctosigmoidoscopy and laboratory findings for complete clinical responses after neoadjuvant chemoradiotherapy in patients with locally advanced primary rectal cancer: a retrospective cohort study"],"prefix":"10.1007","volume":"39","author":[{"given":"Alireza","family":"Hadizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamed","family":"Kazemi-Khaledi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Sadegh","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed-Mohsen","family":"Ahmadi-Tafti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Keshvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Akbari-Asbagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad-Reza","family":"Keramati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Kazemeini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir-Reza","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnam","family":"Behboudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadamin","family":"Parsaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,3]]},"reference":[{"issue":"3","key":"4696_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J Clin 71(3):209\u201349","journal-title":"CA: A Cancer J Clin"},{"issue":"11","key":"4696_CR2","doi-asserted-by":"publisher","first-page":"2758","DOI":"10.1002\/ijc.31785","volume":"143","author":"NPM Brouwer","year":"2018","unstructured":"Brouwer NPM, Bos A, Lemmens V, Tanis PJ, Hugen N, Nagtegaal ID et al (2018) An overview of 25 years of incidence, treatment and outcome of colorectal cancer patients. Int J Cancer 143(11):2758\u20132766","journal-title":"Int J Cancer"},{"issue":"3","key":"4696_CR3","first-page":"145","volume":"70","author":"RL Siegel","year":"2020","unstructured":"Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC et al (2020) Colorectal cancer statistics, 2020. CA: A Cancer J Clin 70(3):145\u201364","journal-title":"CA: A Cancer J Clin"},{"key":"4696_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/annonc\/mdx224","volume":"28","author":"R Glynne-Jones","year":"2017","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, R\u00f6del C, Cervantes A et al (2017) Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Annals Oncol 28:22\u201340","journal-title":"Annals Oncol"},{"issue":"7","key":"4696_CR5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.6004\/jnccn.2020.0032","volume":"18","author":"AB Benson","year":"2020","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK et al (2020) NCCN guidelines insights: rectal cancer, Version 6.2020. J National Compr Cancer Netw 18(7):806\u201315","journal-title":"J National Compr Cancer Netw"},{"issue":"12","key":"4696_CR6","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.ejso.2015.09.008","volume":"41","author":"GL Beets","year":"2015","unstructured":"Beets GL, Figueiredo NL, Habr-Gama A, van de Velde CJH (2015) A new paradigm for rectal cancer: organ preservation: introducing the International Watch & Wait Database (IWWD). Eur J Surg Oncol 41(12):1562\u20131564","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"4696_CR7","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/jnci\/djaa003","volume":"112","author":"JA Miller","year":"2020","unstructured":"Miller JA, Wang H, Chang DT, Pollom EL (2020) Cost-effectiveness and quality-adjusted survival of watch and wait after complete response to chemoradiotherapy for rectal cancer. J National Cancer Inst 112(8):792\u2013801","journal-title":"J National Cancer Inst"},{"issue":"3","key":"4696_CR8","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1245\/s10434-021-10576-z","volume":"29","author":"CL Cui","year":"2022","unstructured":"Cui CL, Luo WY, Cosman BC, Eisenstein S, Simpson D, Ramamoorthy S, Murphy J, Lopez N (2022) Cost effectiveness of watch and wait versus resection in rectal cancer patients with complete clinical response to neoadjuvant chemoradiation. Ann Surg Oncol 29(3):1894\u20131907. https:\/\/doi.org\/10.1245\/s10434-021-10576-z","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4696_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12957-021-02415-y","volume":"19","author":"G Yu","year":"2021","unstructured":"Yu G, Lu W, Jiao Z, Qiao J, Ma S, Liu X (2021) A meta-analysis of the watch-and-wait strategy versus total mesorectal excision for rectal cancer exhibiting complete clinical response after neoadjuvant chemoradiotherapy. World J Surg Oncol 19(1):305","journal-title":"World J Surg Oncol"},{"issue":"1","key":"4696_CR10","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1016\/j.ijrobp.2019.06.595","volume":"105","author":"P Bulens","year":"2019","unstructured":"Bulens P, Debucquoy A, Joye I, Wolthuis A, D\u2019Hoore A, Van Cutsem E et al (2019) Patient-reported functional outcome of patients with rectal cancer undergoing watch-and-wait vs surgery after chemoradiotherapy. Int J Radiat Oncol, Biol, Phys 105(1):S105","journal-title":"Int J Radiat Oncol, Biol, Phys"},{"key":"4696_CR11","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12957-020-02003-6","volume":"18","author":"Gh Zhao","year":"2020","unstructured":"Zhao Gh, Deng L, Ye Dm et al (2020) Efficacy and safety of wait and see strategy versus radical surgery and local excision for rectal cancer with cCR response after neoadjuvant chemoradiotherapy: a meta-analysis. World J Surg Onc 18:232. https:\/\/doi.org\/10.1186\/s12957-020-02003-6","journal-title":"World J Surg Onc"},{"issue":"1","key":"4696_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/jso.26247","volume":"123","author":"NM Sell","year":"2021","unstructured":"Sell NM, Qwaider YZ, Goldstone RN, Cauley CE, Cusack JC, Ricciardi R et al (2021) Ten-year survival after pathologic complete response in rectal adenocarcinoma. J Surg Oncol 123(1):293\u2013298","journal-title":"J Surg Oncol"},{"issue":"5","key":"4696_CR13","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1245\/s10434-018-07147-0","volume":"26","author":"T Wan","year":"2019","unstructured":"Wan T, Zhang XF, Liang C, Liao CW, Li JY, Zhou YM (2019) The prognostic value of a pathologic complete response after neoadjuvant therapy for digestive cancer: systematic review and meta-analysis of 21 studies. Ann Surg Oncol 26(5):1412\u20131420","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4696_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-021-08922-1","volume":"21","author":"J-Y Li","year":"2021","unstructured":"Li J-Y, Huang X-Z, Gao P, Song Y-X, Chen X-W, Lv X-E et al (2021) Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data. BMC Cancer 21(1):1\u201311","journal-title":"BMC Cancer"},{"issue":"12","key":"4696_CR15","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1007\/DCR.0b013e3181f42b89","volume":"53","author":"A Habr-Gama","year":"2010","unstructured":"Habr-Gama A, Perez RO, Wynn G, Marks J, Kessler H, Gama-Rodrigues J (2010) Complete clinical response after neoadjuvant chemoradiation therapy for distal rectal cancer: characterization of clinical and endoscopic findings for standardization. Dis Colon Rectum 53(12):1692\u20131698","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"4696_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/DCR.0b013e3182a84eba","volume":"57","author":"FM Smith","year":"2014","unstructured":"Smith FM, Wiland H, Mace A, Pai RK, Kalady MF (2014) Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy. Dis Colon Rectum 57(3):311\u2013315","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"4696_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/DCR.0000000000000558","volume":"59","author":"SC Nahas","year":"2016","unstructured":"Nahas SC, RizkallahNahas CS, Sparapan Marques CF, Ribeiro U Jr, Cotti GC, Imperiale AR et al (2016) Pathologic complete response in rectal cancer: can we detect it? Lessons learned from a proposed randomized trial of watch-and-wait treatment of rectal cancer. Dis Colon Rectum 59(4):255\u2013263","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"4696_CR18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00384-018-3033-7","volume":"33","author":"A Garant","year":"2018","unstructured":"Garant A, Florianova L, Gologan A, Spatz A, Faria J, Morin N et al (2018) Do clinical criteria reflect pathologic complete response in rectal cancer following neoadjuvant therapy? Int J Colorectal Dis 33(6):727\u2013733","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"4696_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S1072-7515(01)01159-0","volume":"194","author":"SP Hiotis","year":"2002","unstructured":"Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG et al (2002) Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 194(2):131\u2013135","journal-title":"J Am Coll Surg"},{"issue":"7","key":"4696_CR20","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/bjs.8732","volume":"99","author":"R Glynne-Jones","year":"2012","unstructured":"Glynne-Jones R, Hughes R (2012) Critical appraisal of the \u2018wait and see\u2019approach in rectal cancer for clinical complete responders after chemoradiation. J British Surg 99(7):897\u2013909","journal-title":"J British Surg"},{"issue":"3","key":"4696_CR21","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.ijrobp.2021.07.370","volume":"111","author":"J Hill","year":"2021","unstructured":"Hill J, Yang F, Abraham A, Ghosh S, Steed TM, Kurtz C et al (2021) Tumor volume predicts for pathological complete response in rectal cancer patients treated with neoadjuvant chemoradiation. Int J Radiat Oncol Biol Phys 111(3):e44","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4696_CR22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3389\/fonc.2015.00286","volume":"5","author":"DS Bitterman","year":"2015","unstructured":"Bitterman DS, Resende Salgado L, Moore HG, Sanfilippo NJ, Gu P, Hatzaras I, Du KL (2015) Predictors of complete response and disease recurrence following chemoradiation for rectal cancer. Front Oncol 5:286. https:\/\/doi.org\/10.3389\/fonc.2015.00286","journal-title":"Front Oncol"},{"issue":"1","key":"4696_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12029-013-9546-y","volume":"45","author":"AL Russo","year":"2014","unstructured":"Russo AL, Ryan DP, Borger DR, Wo JY, Szymonifka J, Liang W-Y et al (2014) Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer. J Gastrointest Cancer 45(1):34\u201339","journal-title":"J Gastrointest Cancer"},{"issue":"6","key":"4696_CR24","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/DCR.0b013e3182837e5b","volume":"56","author":"JW Huh","year":"2013","unstructured":"Huh JW, Kim HR, Kim YJ (2013) Clinical prediction of pathological complete response after preoperative chemoradiotherapy for rectal cancer. Dis Colon Rectum 56(6):698\u2013703","journal-title":"Dis Colon Rectum"},{"key":"4696_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3389\/fonc.2019.00497","volume":"9","author":"Y Tan","year":"2019","unstructured":"Tan Y, Fu D, Li D, Kong X, Jiang K, Chen L, Yuan Y, Ding K (2019) Predictors and risk factors of pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer: a population-based analysis. Front Oncol 9:497. https:\/\/doi.org\/10.3389\/fonc.2019.00497","journal-title":"Front Oncol"},{"issue":"4","key":"4696_CR26","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1245\/s10434-015-5017-y","volume":"23","author":"E Al-Sukhni","year":"2016","unstructured":"Al-Sukhni E, Attwood K, Mattson DM, Gabriel E, Nurkin SJ (2016) Predictors of pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer. Ann Surg Oncol 23(4):1177\u20131186","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"4696_CR27","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1007\/s11605-015-2814-3","volume":"19","author":"A Kleiman","year":"2015","unstructured":"Kleiman A, Al-Khamis A, Farsi A, Kezouh A, Vuong T, Gordon PH et al (2015) Normalization of CEA levels post-neoadjuvant therapy is a strong predictor of pathologic complete response in rectal cancer. J Gastrointest Surg 19(6):1106\u20131112","journal-title":"J Gastrointest Surg"},{"issue":"7","key":"4696_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1097\/DCR.0b013e31828e5a72","volume":"56","author":"U Wallin","year":"2013","unstructured":"Wallin U, Rothenberger D, Lowry A, Luepker R, Mellgren A (2013) CEA \u2013 a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer. Dis Colon Rectum 56(7):859\u2013868","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"4696_CR29","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3390\/cancers14030491","volume":"14","author":"F Aires","year":"2022","unstructured":"Aires F, Rodrigues D, Lamas MP, Herdeiro MT, Figueiras A, Oliveira MJ et al (2022) C-reactive protein as predictive biomarker for response to chemoradiotherapy in patients with locally advanced rectal cancer: a retrospective study. Cancers 14(3):491","journal-title":"Cancers"},{"issue":"7624","key":"4696_CR30","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","volume":"335","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, Initiative STROBE (2007) Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335(7624):806\u2013808. https:\/\/doi.org\/10.1136\/bmj.39335.541782.AD","journal-title":"BMJ"},{"issue":"2","key":"4696_CR31","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF01645318","volume":"3","author":"P Quirke","year":"1988","unstructured":"Quirke P, Dixon M (1988) The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis 3(2):127\u2013131","journal-title":"Int J Colorectal Dis"},{"issue":"3","key":"4696_CR32","doi-asserted-by":"publisher","first-page":"998","DOI":"10.4143\/crt.2015.254","volume":"48","author":"SH Kim","year":"2016","unstructured":"Kim SH, Chang HJ, Kim DY, Park JW, Baek JY, Kim SY et al (2016) What is the ideal tumor regression grading system in rectal cancer patients after preoperative chemoradiotherapy? Cancer Res Treat 48(3):998\u20131009","journal-title":"Cancer Res Treat"},{"issue":"1","key":"4696_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1245\/s10434-017-6213-8","volume":"25","author":"BJ Hupkens","year":"2018","unstructured":"Hupkens BJ, Maas M, Martens MH, van der Sande ME, Lambregts DM, Breukink SO et al (2018) Organ preservation in rectal cancer after chemoradiation: should we extend the observation period in patients with a clinical near-complete response? Ann Surg Oncol 25(1):197\u2013203","journal-title":"Ann Surg Oncol"},{"key":"4696_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13014-016-0598-6","volume":"11","author":"A Habr-Gama","year":"2016","unstructured":"Habr-Gama A, Perez RO, S\u00e3o Juli\u00e3o GP, Proscurshim I, Fernandez LM, Figueiredo MN et al (2016) Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism compared to standard CRT regimen. Radiat Oncol (London, England) 11:24","journal-title":"Radiat Oncol (London, England)"},{"issue":"8","key":"4696_CR35","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10151-013-1113-9","volume":"18","author":"RO Perez","year":"2014","unstructured":"Perez RO, Habr-Gama A, S\u00e3o Juli\u00e3o GP, Lynn PB, Sabbagh C, Proscurshim I et al (2014) Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET\/CT imaging. Tech Coloproctol 18(8):699\u2013708","journal-title":"Tech Coloproctol"},{"issue":"4","key":"4696_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1097\/DCR.0000000000000742","volume":"60","author":"K Kawai","year":"2017","unstructured":"Kawai K, Ishihara S, Nozawa H, Hata K, Kiyomatsu T, Morikawa T et al (2017) Prediction of pathological complete response using endoscopic findings and outcomes of patients who underwent watchful waiting after chemoradiotherapy for rectal cancer. Dis Colon Rectum 60(4):368\u2013375","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"4696_CR37","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1245\/s10434-015-4687-9","volume":"22","author":"M Maas","year":"2015","unstructured":"Maas M, Lambregts DM, Nelemans PJ, Heijnen LA, Martens MH, Leijtens JW et al (2015) Assessment of clinical complete response after chemoradiation for rectal cancer with digital rectal examination, endoscopy, and MRI: selection for organ-saving treatment. Ann Surg Oncol 22(12):3873\u20133880","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"4696_CR38","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1097\/SLA.0000000000003718","volume":"274","author":"ME van der Sande","year":"2021","unstructured":"van der Sande ME, Maas M, Melenhorst J, Breukink SO, van Leerdam ME, Beets GL (2021) Predictive value of endoscopic features for a complete response after chemoradiotherapy for rectal cancer. Ann Surg 274(6):e541\u2013e547","journal-title":"Ann Surg"},{"key":"4696_CR39","first-page":"24","volume":"12","author":"Y-H Lai","year":"2023","unstructured":"Lai Y-H, Chang Y-T, Chang Y-J, Tsai J-T, Li M-H, Lin J-C (2023) Predictive value of the interaction between CEA and hemoglobin in neoadjuvant CCRT outcomes in rectal cancer patients. J Clin Med 12:24","journal-title":"J Clin Med [Internet]"},{"issue":"6","key":"4696_CR40","first-page":"943","volume":"17","author":"H Ahmadi Amoli","year":"2022","unstructured":"Ahmadi Amoli H, Zarei R, TayefehNorooz M, Najjari K, Zabihi MH (2022) Predicting rectal tumor response to neoadjuvant chemoradiotherapy using plasma levels of carcinoembryonic antigen (CEA): Results from a tertiary center in Iran. J Taibah Univ Med Sci 17(6):943\u2013949","journal-title":"J Taibah Univ Med Sci"},{"issue":"2","key":"4696_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3393\/ac.2021.01004.0143","volume":"38","author":"S An","year":"2022","unstructured":"An S, Shim H, Kim K, Kim B, Bang HJ, Do H et al (2022) Pretreatment inflammatory markers predicting treatment outcomes in colorectal cancer. Ann Coloproctol 38(2):97\u2013108","journal-title":"Ann Coloproctol"},{"issue":"10139","key":"4696_CR42","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/S0140-6736(18)31078-X","volume":"391","author":"MJ van der Valk","year":"2018","unstructured":"van der Valk MJ, Hilling DE, Bastiaannet E, Kranenbarg EM-K, Beets GL, Figueiredo NL et al (2018) Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre registry study. The Lancet 391(10139):2537\u201345","journal-title":"The Lancet"},{"issue":"4","key":"4696_CR43","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s00330-017-5026-2","volume":"28","author":"RGH Beets-Tan","year":"2018","unstructured":"Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Curvo-Semedo L et al (2018) Magnetic resonance imaging for clinical management of rectal cancer: updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. Eur Radiol 28(4):1465\u20131475","journal-title":"Eur Radiol"},{"key":"4696_CR44","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/S2589-7500(21)00215-6","volume":"4","author":"L Feng","year":"2022","unstructured":"Feng L, Liu Z, Li C, Li Z, Lou X, Lizhi S et al (2022) Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. Lancet Digital Health 4:e8\u2013e17","journal-title":"Lancet Digital Health"},{"issue":"1","key":"4696_CR45","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1038\/s41598-021-84816-3","volume":"11","author":"A Delli Pizzi","year":"2021","unstructured":"Delli Pizzi A, Chiarelli AM, Chiacchiaretta P, d\u2019Annibale M, Croce P, Rosa C et al (2021) MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer. Sci Rep 11(1):5379","journal-title":"Sci Rep"},{"issue":"3","key":"4696_CR46","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00330-018-5683-9","volume":"29","author":"Y Cui","year":"2019","unstructured":"Cui Y, Yang X, Shi Z, Yang Z, Du X, Zhao Z et al (2019) Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 29(3):1211\u20131220","journal-title":"Eur Radiol"},{"issue":"11","key":"4696_CR47","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1055\/s-0042-118087","volume":"48","author":"JE East","year":"2016","unstructured":"East JE, Vleugels JL, Roelandt P, Bhandari P, Bisschops R, Dekker E et al (2016) Advanced endoscopic imaging: European Society of Gastrointestinal Endoscopy (ESGE) Technology Review. Endoscopy 48(11):1029\u20131045","journal-title":"Endoscopy"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-024-04696-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-024-04696-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-024-04696-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T16:03:48Z","timestamp":1722701028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-024-04696-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,3]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4696"],"URL":"https:\/\/doi.org\/10.1007\/s00384-024-04696-7","relation":{},"ISSN":["1432-1262"],"issn-type":[{"type":"electronic","value":"1432-1262"}],"subject":[],"published":{"date-parts":[[2024,8,3]]},"assertion":[{"value":"22 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional ethical review board of Tehran University of Medical Sciences (IR.TUMS.IKHC.REC.1398.182). All methods were performed in accordance with the relevant guidelines and regulations of the institutional ethical review board and in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"124"}}